Galera Therapeutics, Inc. — SC 13G Filings
16 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Galera Therapeutics, Inc. (GRTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Galera Therapeutics, Inc. has filed 16 SC 13G documents with the SEC since 2012. To view all SEC filings by Galera Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
25-NSE
3
4
4/A
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | SCHEDULE 13G | 0001213900-24-044069 | May 16, 2024 | — |
| SC 13G | SCHEDULE 13G | 0001376474-24-000167 | Apr 16, 2024 | — |
| SC 13G | SCHEDULE 13G | 0001213900-24-003834 | Jan 17, 2024 | — |
| SC 13G | — | 0001362033-24-000001 | Jan 2, 2024 | — |
| SC 13G | SC 13G | 0001104659-23-117077 | Nov 13, 2023 | — |
| SC 13G | — | 0001193805-23-000248 | Feb 28, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-019589 | Feb 13, 2023 | — |
| SC 13G | SC 13G | 0001019056-22-000175 | Feb 11, 2022 | — |
| SC 13G | GALERA THERAPEUTICS, INC. | 0001104659-21-153570 | Dec 27, 2021 | — |
| SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-21-005118 | Apr 30, 2021 | — |
| SC 13G | SC 13G | 0001104659-20-121394 | Nov 4, 2020 | — |
| SC 13G | SC 13G | 0001193125-20-037983 | Feb 14, 2020 | — |
| SC 13G | NEW ENTERPRISE ASSOCIATES 14, L.P. - GALERA THERAPEUTICS, INC. -- SCHEDULE 13G | 0001072613-20-000090 | Feb 13, 2020 | — |
| SC 13G | SC 13G | 0001193125-19-297713 | Nov 21, 2019 | — |
| SC 13G | — | 0000902664-19-004370 | Nov 15, 2019 | — |
| SC 13G | SC 13G | 0001193125-19-292207 | Nov 14, 2019 | — |